APO-ANASTROZOLE 1 MG
ANASTROZOLE : 1 MG · DIN 02374420 · APOTEX INC
Health Canada status: MARKETED
What is APO-ANASTROZOLE?
APO-ANASTROZOLE 1 MG contains ANASTROZOLE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02374420, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 25-Oct-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-ANASTROZOLE used for?
Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer; Hormonal treatment of advanced breast cancer in postmenopausal women.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02374420 |
|---|---|
| Brand name | APO-ANASTROZOLE |
| Generic / active ingredient | ANASTROZOLE : 1 MG |
| Manufacturer | APOTEX INC |
| Strength | 1 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | L02BG03 ANASTROZOLE |
| AHFS class | 10:00.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 25-Oct-2012 |
| Original market date | 2012-10-25 00:00:00 |
How is it administered?
1 mg orally, once a day. In the adjuvant setting, recommended treatment is 5 years. Swallow with fluids at the same time each day.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
(Not explicitly detailed in provided text snippet, though section 11 is listed in Table of Contents).
How is it supplied?
Available in bottles of 100 and blisters of 30.
Contraindications
Hypersensitivity to anastrozole or any ingredient in the formulation; Pregnant or lactating women.
Warnings and precautions
Not for pre-menopausal women. Risk of decreased bone mineral density/fractures. Ischemic cardiovascular events reported. Potential for tendonitis, tenosynovitis, and rare tendon rupture.
What can be used instead?
Other Canadian products sharing ATC code L02BG03 ANASTROZOLE. 18 of 30 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-ANASTROZOLE | 1 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02351218 |
| AG-ANASTROZOLE TABLETS | 1 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02553686 |
| ANASTROZOLE | 1 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02529904 |
| ANASTROZOLE | 1 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 02395649 |
| ANASTROZOLE | 1 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02442736 |
| ARIMIDEX | 1 MG | TABLET | ASTRAZENECA CANADA INC | MARKETED | DIN 02224135 |
| BIO-ANASTROZOLE | 1 MG | TABLET | BIOMED PHARMA | MARKETED | DIN 02392488 |
| JAMP ANASTROZOLE TABLETS | 1 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02540584 |
| JAMP-ANASTROZOLE | 1 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02339080 |
| MAR-ANASTROZOLE | 1 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02379562 |
Who else supplies ANASTROZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ANASTROZOLE appears in 148 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.